Clinical epidemiological characteristics and antibiotic sensitivity of Escherichia coli urinary tract infection
PLOS One · 2025
DOI: 10.1371/journal.pone.0336572 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Zhi Wen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Affiliated Xuancheng Hospital of Wannan Medical College, Xuancheng, Anhui, China. Hauptthemen laut MEDLINE: Urinary Tract Infections, Escherichia coli, Anti-Bacterial Agents, Escherichia coli Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Provincial Health Commission Scientific Research Project.
Abstract (Originalsprache)
Introduction
Urinary tract infections are common types of infections around the world, and most urinary tract infections are caused by Escherichia coli ( E. coli ). In order to better understand the clinical characteristics of E. coli in urinary tract infections and to guide empirical treatment, we conducted this study.
Methods
E. coli in hospitalized patients with urinary tract infection in 2023 was retrospectively analyzed. Urine culture was determined and analyzed for patients with urinary tract infections admitted to Xuancheng People’s Hospital from 01/01/2023–31/12/2023. More than 10 5 cfu/ml in the urine culture supernatant is of great significance to urinary tract infection. According to needs, the identification and drug sensitivity tests were carried out using standard laboratory technology and automated system of France, VITEK 2 Compact, and the Clinical Laboratory Standards Institute (CLSI) standard was adopted.
Results
A total of 401 strains were isolated from patients with urinary tract infections, including 62 hospital-acquired infections and 339 community acquired infections. Hospital-acquired infections were mainly ESBL-positive bacteria, and the general hospitalization time was about one month. Community acquired infections were mainly ESBL-negative bacteria. The hospital stay was about 10 days. The antibiotic susceptibility profiles were as follows: tigecycline (99.8%), imipenem (99.3%), ertapenem (99.3%), amikacin (98.3%), piperacillin/tazobactam (92.3%), cefxitin (87.3%), cefoperazone/sulbactam (85.8%), amoxicillin/clavulanate (76.6%), cefepime (76.3%), ceftazidime (75.6%), ceftriaxone (65.8%), trimethoprim/sulfamethoxazole (64.1%), ceffuroxime sodium (56.6%), cefuroximethoxazole (56.6%), and levofloxacin (21.9%).
Conclusion
Urinary tract infections caused by E. coli are predominantly community acquired, accounting for 84.5%(339/401), and most cases involved ESBL-negative strains. Therefore, third-generation cephalosporins remain the preferred choice for empirical treatment, while quinolones and second-generation cephalosporins are not recommended. Subsequently, the treatment regimen can be de-escalated based on confirmed infection type and patient condition, an approach that has been associated with reduced hospitalization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Affiliated Xuancheng Hospital of Wannan Medical College, Xuancheng, Anhui, China.
ORCID-Profile: Zhi Wen
Förderung
- Anhui Provincial Health Commission Scientific Research Project
Zitieren
APA
Wen, Z., Jin, J., Chen, Y., Zhao, C., Xu, C., Liu, J., & Ge, B. (2025). Clinical epidemiological characteristics and antibiotic sensitivity of Escherichia coli urinary tract infection. PLOS One. https://doi.org/10.1371/journal.pone.0336572
Vancouver
Wen Z, Jin J, Chen Y, Zhao C, Xu C, Liu J, et al. Clinical epidemiological characteristics and antibiotic sensitivity of Escherichia coli urinary tract infection. PLOS One. 2025. doi:10.1371/journal.pone.0336572
BibTeX
@article{Wen2025,
author = {Wen, Zhi and Jin, Jiwei and Chen, Yonghong and Zhao, Chengjuan and Xu, Chengchun and Liu, Jun and Ge, Binglei},
title = {Clinical epidemiological characteristics and antibiotic sensitivity of Escherichia coli urinary tract infection},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0336572}
}
EUVIMED